Guoliang Wang
Papers
2
Total Citations
17
H-Index
2
About
Guoliang Wang is a urologic oncologist whose research focuses on the surgical management of renal cell carcinoma (RCC) complicated by venous tumor thrombus (VTT). His work centers on comparing surgical approaches—robotic, laparoscopic, and open—for radical nephrectomy with thrombectomy, a high-risk procedure for advanced kidney cancer. Wang’s most-cited study (14 citations) is a propensity-matched cohort analysis demonstrating that robotic and laparoscopic techniques yield comparable oncologic outcomes to open surgery, with potential benefits in recovery. He has also conducted a systematic review (2025) examining risk factors for postoperative renal insufficiency, a critical concern given that nephrectomy inherently reduces kidney function. This review provides evidence-based guidance for preserving renal health in patients undergoing this demanding operation. Wang’s contributions are particularly valuable for surgeons navigating the trade-offs between minimally invasive approaches and renal function preservation. His work has been cited in leading urology journals and informs clinical decision-making for one of the most challenging scenarios in kidney cancer surgery. By systematically evaluating outcomes and complications, Wang helps refine surgical strategies to improve both survival and quality of life for patients with RCC and VTT.
Research Focus
Key Achievements
Top Papers
- 1
- 2